# K080379: Micrus Microcoil System, Deltapaq 10 Stretch Resistant

- Pathway: 510(k) (Traditional)
- Applicant: Micrus Endovascular Corporation
- Decided: Jun 30, 2008 after 138 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K951256 (1995). 25 ancestors in all.
10 later devices descend from it; 3 cite it directly.
1 of 36 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K022420: Micrus Stretch-Resistant Microcoil System, MSR01, Micrus Corp. (2002) Summary page 1.

## Most influential descendants
- K082739: Micrus Microcoil Delivery System (2008), 7 descendants of its own
- K150319: Micrusframe 10/18, Deltafill 18, Deltaxsft 10, Galaxy G3 Fill/XSFT Stretch Resistant Microcoil Delivery Systems (2015), 5 descendants of its own
- K171862: GALAXY G3 Mini Microcoil Delivery System (2017), 2 descendants of its own
- K171747: MICRUSFRAME 10 Stretch Resistant Microcoil Delivery System,  MICRUSFRAME 18 Stretch Resistant Microcoil Delivery System, DELTAFILL 18 Stretch Resistant Microcoil Delivery System, DELTAXSFT 10 Stretch Resistant Microcoil Delivery System, GALAXY G3 FILL and GALAXY G3 XSFT Stretch Resistant Microcoil Delivery System (2017), 2 descendants of its own
- K211344: MICRUSFRAME, DELTAFILL, DELTAXSFT, GALAXY G3, GALAXY G3 XSFT, and GALAXY G3 Mini Microcoil Delivery Systems (2021), 1 descendant of its own

## Indications for use
The Micrus Microcoil Delivery System is intended for endovascular embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and are also intended for arterial and venous embolizations in the peripheral vasculature.

Source page: https://510kreport.com/device/K080379
Methodology: https://510kreport.com/methodology